NCT00237367View on ClinicalTrials.gov

A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2005

Conditions
Gastroesophageal Reflux
Interventions
DRUG

rabeprazole and pantoprazole

All Listed Sponsors
collaborator

Eisai Inc.

INDUSTRY

lead

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

NCT00237367 - A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn | Biotech Hunter | Biotech Hunter